Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Bimekizumab Reduces Uveitis Incidence in axSpA Patients
The study led by Matthew A. Brown, Genomics England, London, United Kingdom, and Martin Rudwaleit, Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany. Patients with axial spondyloarthritis (axSpA) treated with bimekizumab exhibited a markedly lower incidence of uveitis compared to those receiving…
Nerve Regrowth Breakthrough for Blindness
Researchers at the University of Connecticut have uncovered promising findings that may pave the way for treating a common cause of blindness. The study, published in the September issue of Experimental Neurology, demonstrates how injured optic nerves in mice can…
U.S. Glaucoma Prevalence and Risk Factors Study
A new study titled “Prevalence of Glaucoma Among US Adults in 2022”, published in JAMA Ophthalmology, has revealed updated statistics on the prevalence of glaucoma in the United States. The research shows that approximately 4.22 million U.S. adults (1.62% of…
AI Diagnoses Corneal Infections as Accurately as Doctors
Artificial intelligence (AI) is emerging as a valuable tool in diagnosing infectious keratitis (IK), a leading cause of corneal blindness worldwide. A recent study published in eClinicalMedicine has shown that deep learning (DL) models demonstrate similar diagnostic accuracy to ophthalmologists…
Cataract Surgery Lowers Risk of Falls and Injuries
Cataract surgery is well-known for restoring vision, but a new study reveals it may also play a vital role in reducing life-threatening injuries. Research presented at the annual meeting of the American Academy of Ophthalmology in Chicago suggests that older…
Ocular Side Effects Linked to Ovarian Cancer Drug
A recent study presented at the American Academy of Ophthalmology (AAO) meeting in Chicago has identified significant ocular side effects associated with mirvetuximab soravtansine (Elahere), a drug approved for ovarian cancer treatment. The research, conducted by Stanford University, highlights the…
New Imaging Boosts Geographic Atrophy Diagnosis
At the 2024 American Academy of Ophthalmology (AAO) meeting in Chicago, Dr. SriniVas R. Sadda discussed the evolving landscape of imaging technologies for diagnosing geographic atrophy (GA). While traditional methods like flash color fundus photography have been the gold standard…
ANX007 Protects Vision in Dry AMD – AAO 2024
A new investigational drug, ANX007, offers hope for the millions of people suffering from geographic atrophy, a severe form of dry age-related macular degeneration (AMD). The drug’s potential to reduce vision loss and protect essential retinal structures was highlighted at…
Long-Term Antiviral Therapy for Ocular Shingles
A new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania and the NYU Grossman School of Medicine suggests that taking an antiviral medication for a year can help prevent vision loss caused by…
SLT Beats Medications in Glaucoma – AAO 2024
A recent retrospective analysis of the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial data demonstrated that selective laser trabeculoplasty (SLT) as a first-line treatment significantly outperforms glaucoma medications in reducing the rate of visual field (VF) loss. This study,…